ResMed News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

24.10.24	Resmed Inc Q1 Profit Increases, Beats Estimates (RTTNews)
10.09.24	Vaping Expected to Increase COPD Health and Economic Burden by 2050 (GlobeNewswire)
02.08.24	Resmed Inc Q4 Profit Increases, Beats Estimates (RTTNews)
10.06.24	PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia (GlobeNewswire)
25.04.24	Resmed Inc Q3 Profit Increases, beats estimates (RTTNews)
15.03.24	ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis (GlobeNewswire)
24.01.24	Resmed Inc Q2 Profit Decreases, but beats estimates (RTTNews)
09.11.23	ResMed Adopts New Operating Model to Accelerate Long-term Growth (GlobeNewswire)
26.10.23	Resmed Inc Q1 Profit Increases, beats estimates (RTTNews)
03.08.23	Resmed Inc Q4 Profit Increases, but misses estimates (RTTNews)
05.07.23	ResMed Acquires Somnoware, a Leader in Digital Sleep and Respiratory Care Diagnostics Software (GlobeNewswire)
08.06.23	PAP Adherence Lowers ER Visits 24-36% in 1 Year for People with Sleep Apnea and Heart Failure: ResMed Studies Presented at SLEEP (GlobeNewswire)
25.05.23	3 World-Renowned Sleep Apnea Experts Present New Benefits of PAP Therapies at ATS 2023 (GlobeNewswire)
02.05.23	ResMed Appoints Michael Rider its Next Global General Counsel, Dawn Haake its First Chief Quality Officer (GlobeNewswire)
30.03.23	ResMed Chief Administrative Officer and Global General Counsel to Retire (GlobeNewswire)
13.03.23	ResMed’s Annual Global Sleep Survey Finds 8 in 10 Adults Experience Signs of Disruption Related to Their Quality of Sleep (GlobeNewswire)
26.01.23	Resmed Inc Q2 Profit Increases, beats estimates (RTTNews)
29.11.22	Form 4 943819 (RSS)
22.11.22	ResMed Completes Acquisition of MEDIFOX DAN, a German Leader in Out-of-Hospital Care Management Software Solutions (GlobeNewswire)
18.11.22	Form 4 943819 (RSS)
17.11.22	Form 8-K 943819 (RSS)
09.11.22	Form 4 943819 (RSS)
02.11.22	Form 4 943819 (RSS)
28.10.22	Form 10-Q 943819 (RSS)
28.10.22	Resmed Inc Q1 Profit Increases, but misses estimates (RTTNews)
27.10.22	Form 8-K 943819 (RSS)
05.10.22	Other definitive proxy statements (RSS)
04.09.22	Over 480 Million People Estimated to Have COPD, World’s Third Deadliest Disease, ResMed Study Reports (GlobeNewswire)
22.08.22	Statement of changes in beneficial ownership of securities (RSS)
18.08.22	Annual statement of changes in beneficial ownership of securities (RSS)
17.08.22	Annual statement of changes in beneficial ownership of securities (RSS)
12.08.22	Current report (RSS)
11.08.22	Resmed Inc Q4 sales increase (RTTNews)
28.06.22	ResMed Promotes Lucile Blaise to President, Sleep & Respiratory Care (GlobeNewswire)
16.06.22	Statement of changes in beneficial ownership of securities (RSS)
14.06.22	ResMed to Acquire MEDIFOX DAN, a German Leader in Out-of-Hospital Software Solutions (GlobeNewswire)
25.05.22	ResMed Announces Participation in the 38th Annual Bernstein Strategic Decisions Conference (GlobeNewswire)
18.05.22	Even 2 Hours of PAP Therapy per Night Benefits Sleep Apnea Sufferers: ResMed Study (GlobeNewswire)
17.05.22	Statement of changes in beneficial ownership of securities (RSS)
05.05.22	ResMed Announces Leadership Change (GlobeNewswire)
29.04.22	Form 10-Q 943819 (RSS)
28.04.22	Resmed Inc Q3 Earnings Summary (RTTNews)
28.04.22	Form 8-K 943819 (RSS)
27.04.22	ResMed Announces Participation in the 24th Annual Macquarie Australia Conference (GlobeNewswire)
07.04.22	ResMed to Report Third Quarter Fiscal 2022 Earnings on April 28, 2022 (GlobeNewswire)
05.04.22	Form 4 943819 (RSS)
17.03.22	ResMed Announces Participation in the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum (GlobeNewswire)
14.03.22	ResMed’s Global Sleep Surveys Reveal What’s Keeping Us Up at Night; Aim to Bring Awareness to the State of Sleep Health for World Sleep Day (GlobeNewswire)
14.03.22	Form 4 943819 (RSS)
10.03.22	ResMed Announces Participation in the Oppenheimer 32nd Annual Healthcare Conference (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

23.12.24		Gewinne in New York: S&P 500 legt am Nachmittag zu
23.12.24		Freundlicher Handel: S&P 500 mit positivem Vorzeichen
23.12.24		Optimismus in New York: S&P 500 legt zum Handelsstart zu
18.12.24		Börse New York: Börsianer lassen S&P 500 am Nachmittag steigen
22.11.24		S&P 500-Wert ResMed-Aktie: Über diese Dividendenzahlung können sich ResMed-Anleger freuen
21.11.24		Gute Stimmung in New York: S&P 500 zum Handelsende in der Gewinnzone
21.11.24		NYSE-Handel: Börsianer lassen S&P 500 am Donnerstagnachmittag steigen
21.11.24		Starker Wochentag in New York: Gewinne im S&P 500

23.12.24

Gewinne in New York: S&P 500 legt am Nachmittag zu

23.12.24

Freundlicher Handel: S&P 500 mit positivem Vorzeichen

23.12.24

Optimismus in New York: S&P 500 legt zum Handelsstart zu

18.12.24

Börse New York: Börsianer lassen S&P 500 am Nachmittag steigen

22.11.24

S&P 500-Wert ResMed-Aktie: Über diese Dividendenzahlung können sich ResMed-Anleger freuen

21.11.24

Gute Stimmung in New York: S&P 500 zum Handelsende in der Gewinnzone

21.11.24

NYSE-Handel: Börsianer lassen S&P 500 am Donnerstagnachmittag steigen

21.11.24

Starker Wochentag in New York: Gewinne im S&P 500

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu ResMed Inc.

Aktien Top/Flop

ResMed Peer Group Nachrichten

Meistgelesene Nachrichten